Meritxell Espinal-Pons
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.
Journal: Communications biology
Published: December 19, 2024
Acute cerebellar ataxia in Griscelli syndrome type 2
Journal: Revista de neurologia
Published: September 05, 2023
Arrhythmias in patients with X-linked myotubular myopathy.
Journal: Revista de neurologia
Published: July 19, 2023
Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: July 04, 2023
Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A.
Journal: bioRxiv : the preprint server for biology
Published: March 22, 2023
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation.
Journal: EMBO molecular medicine
Published: February 23, 2022
Environmental Enrichment Induces Epigenomic and Genome Organization Changes Relevant for Cognition.
Journal: Frontiers in molecular neuroscience
Published: February 06, 2021
Parkinson's disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration.
Journal: NPJ Parkinson's disease
Published: June 30, 2020
Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells.
Journal: Cellular and molecular life sciences : CMLS
Published: November 14, 2019
Long-Term Labeling of Hippocampal Neural Stem Cells by a Lentiviral Vector.
Journal: Frontiers in molecular neuroscience
Published: June 01, 2018
Last Updated: 09/26/2026